-
Ad hoc approach to using genetically modified pig kidneys poses difficulties ascertaining efficacy despite singular reports of early success.
Medical Mythbusting Commentary for January 31, 2025 Source:Recipient of pig kidney transplant reaches a milestone
-
The ins and outs of prostate cancer screening guidelines
Medical Mythbusting Commentary for November 6, 2024 Source:This Movember, what men should know about getting screened for prostate cancer
-
Radioligand therapy for men with a specific type of prostate cancer can produce positive results but requires full disclosure of the side effects as well.
Medical Mythbusting Commentary for July 11, 2024 Source:Doctors excited about targeted prostate cancer therapy, but can’t prescribe it yet
-
Pig kidney transplanted into living person for first time
Medical Mythbusting Commentary for March 22, 2024 Source:Pig kidney transplanted into living person for first time
-
Prostate cancer screening is not as clear cut as we would like it to be. In the end, a frank discussion about the risks and benefits using the available evidence will allow the patient to decide if they wish to pursue this option.
Medical Mythbusting Commentary for March 5, 2024 Source:What you should know to reduce the risk of prostate cancer Reference:PROSTATE CANCER—CLINICIAN SUMMARY
-
First-of-its-kind erectile dysfunction gel gets FDA’s OK for over-the-counter marketing, company says. I have my doubts about its efficacy based on its ingredient list.
Medical Mythbusting Commentary for June 13, 2023 Source:First-of-its-kind erectile dysfunction gel gets FDA’s OK for over-the-counter marketing, company says
-
Prostate cancer: New combination therapy could reduce progression risk
Medical Mythbusting Commentary for March 27, 2023 Source:Prostate cancer: New combination therapy could reduce progression risk Reference:TALAPRO-2 Supports First-Line Talazoparib/Enzalutamide in All-Comers With mCRPC
-
Prostate Cancer screening blood test uses a combination PSA and epigenetic markers to improve accuracy and reduce false positive results. Further evaluation in larger population cohorts recommended by study authors.
Medical Mythbusting Commentary for February 14, 2023 Source:New blood test may be 94 per cent effective at spotting signs of prostate cancer Reference:Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection
-
New insights into how prostate cancer protects itself from latest therapies after researchers uncover the gene responsible for this resistance while investigating new drug that circumvents these protective mechanisms.
Medical Mythbusting Commentary for November 28, 2022 Source:Drug triggers immune cells to attack prostate cancer Reference:Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.